Minocycline Hydrochloride Tablet, Extended Release
Product Images NDC 68180-379

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Minocycline Hydrochloride (NDC 68180-379). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F2c65361 F13f 4504 B62c 1bb6f39841a3 01

Chemical structure diagram of Minocycline Hydrochloride showing its molecular formula C23H27N3O7•HCl and molecular weight 493.95. The structure includes several hydroxyl groups, ketones, amide, and dimethylamino substituents.*

FDA Label Image

F2c65361 F13f 4504 B62c 1bb6f39841a3 02

Label for Minocycline Hydrochloride Extended-Release Tablets USP, 45 mg strength. The label indicates each film-coated extended-release tablet contains minocycline hydrochloride equivalent to 45 mg of minocycline. The package contains 30 tablets. Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, Maryland, and by Lupin Limited, India. Includes NDC 68180-379-06 and storage instructions.*

FDA Label Image

F2c65361 F13f 4504 B62c 1bb6f39841a3 03

Label for Minocycline Hydrochloride Extended-Release Tablets USP 55 mg, oral tablet form, containing 30 tablets. Manufactured by Lupin Pharmaceuticals, Inc. The label includes dosage storage instructions, a barcode, and identification numbers.*

FDA Label Image

F2c65361 F13f 4504 B62c 1bb6f39841a3 04

Label for Minocycline Hydrochloride Extended-Release Tablets USP, 90 mg strength, oral dosage form. The label indicates each tablet contains minocycline hydrochloride USP equivalent to 90 mg minocycline. Pack contains 30 film-coated extended-release tablets. Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, Maryland, and Lupin Limited, Pithampur, India. Includes storage instructions and a barcode.*

FDA Label Image

F2c65361 F13f 4504 B62c 1bb6f39841a3 05

Label for Minocycline Hydrochloride Extended-Release Tablets USP, 135 mg strength, oral dosage form. The label indicates each film-coated extended-release tablet contains minocycline hydrochloride USP equivalent to 135 mg of minocycline. The package contains 30 tablets, manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, and manufactured by Lupin Limited, India. Storage and dispensing instructions are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.